Mitochondrial depletion syndrome type 3: the Lebanese variant

Introduction: Mitochondrial DNA depletion syndrome type 3 is an emerging disorder linked to variants in the deoxyguanosine kinase gene, which encodes for mitochondrial maintenance. This autosomal recessive disorder is frequent in the Middle East and North Africa. Diagnosis is often delayed due to th...

Full description

Bibliographic Details
Main Authors: Marianne Majdalani, Nadine Yazbeck, Lamis El Harake, Jinane Samaha, Pascale E. Karam
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1215083/full
_version_ 1797792459556651008
author Marianne Majdalani
Nadine Yazbeck
Lamis El Harake
Jinane Samaha
Pascale E. Karam
author_facet Marianne Majdalani
Nadine Yazbeck
Lamis El Harake
Jinane Samaha
Pascale E. Karam
author_sort Marianne Majdalani
collection DOAJ
description Introduction: Mitochondrial DNA depletion syndrome type 3 is an emerging disorder linked to variants in the deoxyguanosine kinase gene, which encodes for mitochondrial maintenance. This autosomal recessive disorder is frequent in the Middle East and North Africa. Diagnosis is often delayed due to the non-specificity of clinical presentation with cerebro-hepatic deterioration. The only therapeutic option is liver transplantation, although the value of this remains debatable.Methods: We describe the clinical, biochemical, and molecular profiles of Lebanese patients with this rare disorder. We also present a review of all cases from the Middle East and North Africa.Results: All Lebanese patients share a unique mutation, unreported in other populations. Almost half of patients worldwide originate from the Middle East and North Africa, with cases reported from only 7 of the 21 countries in this region. Clinical presentation is heterogeneous, with early-onset neurological and hepatic signs. Liver failure and lactic acidosis are constants. Several variants can be identified in each population; a unique c.235C>T p. (Gln79*) pathogenic variant is found in Lebanese patients. Outcome is poor, with death before 1 year of age.Conclusion: The pathogenic nonsense variant c.235C>T p. (Gln79*) in the deoxyguanosine kinase gene may be considered a founder mutation in Lebanon. Further genotypic delineation of this devastating disorder in populations with high consanguinity rates is needed.
first_indexed 2024-03-13T02:34:29Z
format Article
id doaj.art-a89c4c557b3b468aa080432dc66b03e6
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-13T02:34:29Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-a89c4c557b3b468aa080432dc66b03e62023-06-29T09:44:29ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-06-011410.3389/fgene.2023.12150831215083Mitochondrial depletion syndrome type 3: the Lebanese variantMarianne Majdalani0Nadine Yazbeck1Lamis El Harake2Jinane Samaha3Pascale E. Karam4Division of Pediatric Intensive Care Unit, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, LebanonDivision of Gastroenterology, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, LebanonFaculty of Medicine, American University of Beirut, Beirut, LebanonInherited Metabolic Diseases Program, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, LebanonInherited Metabolic Diseases Program, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, LebanonIntroduction: Mitochondrial DNA depletion syndrome type 3 is an emerging disorder linked to variants in the deoxyguanosine kinase gene, which encodes for mitochondrial maintenance. This autosomal recessive disorder is frequent in the Middle East and North Africa. Diagnosis is often delayed due to the non-specificity of clinical presentation with cerebro-hepatic deterioration. The only therapeutic option is liver transplantation, although the value of this remains debatable.Methods: We describe the clinical, biochemical, and molecular profiles of Lebanese patients with this rare disorder. We also present a review of all cases from the Middle East and North Africa.Results: All Lebanese patients share a unique mutation, unreported in other populations. Almost half of patients worldwide originate from the Middle East and North Africa, with cases reported from only 7 of the 21 countries in this region. Clinical presentation is heterogeneous, with early-onset neurological and hepatic signs. Liver failure and lactic acidosis are constants. Several variants can be identified in each population; a unique c.235C>T p. (Gln79*) pathogenic variant is found in Lebanese patients. Outcome is poor, with death before 1 year of age.Conclusion: The pathogenic nonsense variant c.235C>T p. (Gln79*) in the deoxyguanosine kinase gene may be considered a founder mutation in Lebanon. Further genotypic delineation of this devastating disorder in populations with high consanguinity rates is needed.https://www.frontiersin.org/articles/10.3389/fgene.2023.1215083/fullDGUOKmitochondrial depletionmtDNA maintenance defectsMENAneonatal liver failurelactic acidosis
spellingShingle Marianne Majdalani
Nadine Yazbeck
Lamis El Harake
Jinane Samaha
Pascale E. Karam
Mitochondrial depletion syndrome type 3: the Lebanese variant
Frontiers in Genetics
DGUOK
mitochondrial depletion
mtDNA maintenance defects
MENA
neonatal liver failure
lactic acidosis
title Mitochondrial depletion syndrome type 3: the Lebanese variant
title_full Mitochondrial depletion syndrome type 3: the Lebanese variant
title_fullStr Mitochondrial depletion syndrome type 3: the Lebanese variant
title_full_unstemmed Mitochondrial depletion syndrome type 3: the Lebanese variant
title_short Mitochondrial depletion syndrome type 3: the Lebanese variant
title_sort mitochondrial depletion syndrome type 3 the lebanese variant
topic DGUOK
mitochondrial depletion
mtDNA maintenance defects
MENA
neonatal liver failure
lactic acidosis
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1215083/full
work_keys_str_mv AT mariannemajdalani mitochondrialdepletionsyndrometype3thelebanesevariant
AT nadineyazbeck mitochondrialdepletionsyndrometype3thelebanesevariant
AT lamiselharake mitochondrialdepletionsyndrometype3thelebanesevariant
AT jinanesamaha mitochondrialdepletionsyndrometype3thelebanesevariant
AT pascaleekaram mitochondrialdepletionsyndrometype3thelebanesevariant